Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.16
+0.02 (0.39%)
Jul 14, 2026, 4:00 PM EDT - Market closed
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.27 billion as of July 14, 2026. Its market cap has increased by 44.37% in one year.
Market Cap
1.27B
Enterprise Value
1.27B
1-Year Change
44.37%
Ranking
Category
Stock Price
$5.16
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.27B, an increase of 425.20%. That is a compound annual growth rate of 14.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.27B | -10.01% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.36B |
| Immatics | 1.32B |
| Corvus Pharmaceuticals | 1.32B |
| First Tracks Biotherapeutics | 1.26B |
| MannKind | 1.26B |
| Capricor Therapeutics | 1.25B |
| Avalyn Pharma | 1.24B |
| Jade Biosciences | 1.24B |